Supernus Pharmaceuticals | SUPN - Current Assets

Stock Price
49.91
Daily Change
-0.55 -1.09%
Monthly
-3.31%
Yearly
59.66%
Q1 Forecast
48.40

Supernus Pharmaceuticals reported $644.18M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
ANI Pharmaceuticals USD 753.12M 54.72M Dec/2025
Aurora Cannabis CAD 423.84M 41.46M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 445.82M 142.46M Sep/2025
Cara Therapeutics USD 43.13M 4.18M Jun/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Eisai JPY 840.88B 50.18B Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Novo Nordisk DKK 172.45B 9.43B Dec/2025
Pacira USD 547.97M 14.78M Dec/2025
Perrigo USD 2.8B 81.8M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
United Therapeutics USD 3.7B 208.5M Dec/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025